Sarcoma  >>  Promacta (eltrombopag)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Promacta (eltrombopag) / Novartis
NCT01491594: Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Terminated
1/2
1
US
Eltrombopag, Promacta
Duke University, GlaxoSmithKline
Sarcoma, Soft Tissue, Osteosarcoma, Neoplasms, Connective and Soft Tissue
03/13
03/13

Download Options